| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |